Effects of insulin on plasma renin activity, plasma atrial natriuretic peptide and body fluid volume in diabetes mellitus.
The effects of insulin treatment on plasma renin activity (PRA), plasma atrial natriuretic peptide (ANP) and body fluid volume were studied in 16 hospitalized patients with insulin-independent diabetes mellitus. Parameters were recorded for 2 days during treatment by diet alone and for 3 weeks after starting insulin. Blood samples were obtained weekly from 9 patients for the measurement of fasting plasma glucose, hematocrit, PRA and plasma ANP. A 24-hr urine sample was collected to determine the urinary excretion of glucose and sodium. In a separate group of 7 patients, plasma volume and extracellular fluid volume were determined by the Evans blue and sodium thiocyanate dilution tests, respectively. In the group of 9 diabetic patients, significant (p less than 0.05) reductions in fasting plasma glucose, hematocrit and the urinary excretion of sodium and glucose were seen with insulin treatment. PRA fell significantly (p less than 0.05) from 5.2 +/- 1.2 ng/ml/hr (mean +/- SEM) on the control days to 2.3 +/- 0.5 on the 21st day after starting treatment. Plasma levels of ANP averaged 35 +/- 5 pg/ml on the control days and these did not change significantly. In the other group of 7 patients, both plasma volume and extracellular fluid volume increased significantly (p less than 0.05) with insulin treatment. A sodium-retaining effect of insulin and a decrease in osmotic diuresis may have increased the body fluid volume and caused the fall in PRA. Thus, a vasodilatory action of insulin may assist in compensation for the increase in body fluid volume, preventing a rise in plasma ANP levels.
Nakamura
T
T
Second Department of Internal Medicine, Gunma University School of Medicine, Maebashi, Japan.
Ichikawa
S
S
Sakamaki
T
T
Aizawa
F
F
Kurashina
T
T
Sato
K
K
Fujie
M
M
Murata
K
K
D009320:Atrial Natriuretic Factor / Q000097:blood*; D001798:Blood Proteins / Q000032:analysis; D001826:Body Fluids / Q000378:metabolism*; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy / Q000378:metabolism*; D006400:Hematocrit; D006801:Humans; D007328:Insulin / Q000627:therapeutic use*; D009318:Natriuresis; D011188:Potassium / Q000652:urine; D012083:Renin / Q000097:blood*
D001798:Blood Proteins; D007328:Insulin; D009320:Atrial Natriuretic Factor; D012083:Renin; D011188:Potassium